BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE
|
Back to Search Results |
|
Device Problems
Contamination (1120); Improper or Incorrect Procedure or Method (2017)
|
Patient Problem
Peritonitis (2252)
|
Event Date 06/11/2014 |
Event Type
Injury
|
Event Description
|
It was reported that a patient experienced a break in aseptic technique further described as the patient did not wash hands or clean the area before the start of peritoneal dialysis (pd) therapy, which caused peritonitis.On the same day as the onset, the patient was hospitalized for the peritonitis.The treatment was with vancomycin intraperitoneally (ip) (dose and frequency not reported), fortaz ip (dose and frequency not reported), gentamycin ip, (dose and frequency not reported) and cipro orally (dose and frequency not reported) for the peritonitis.The patient was discharged from the hospital after three days.At the time of this report, the patient was recovering from the peritonitis.The pd therapy was ongoing.The patient was retrained on aseptic technique.Additional information was requested but was not available at this time.
|
|
Manufacturer Narrative
|
(b)(4).On an unreported date in the same month as the onset of the peritonitis, the patient was completely recovered from the peritonitis event.Should additional relevant information become available, a follow up report will be submitted.
|
|
Manufacturer Narrative
|
(b)(4).As the sample was not returned and the lot number is unknown, a device analysis cannot be completed.This is a report of a use error that resulted in peritonitis.Per baxter labeling, users are instructed to use aseptic technique when performing peritoneal dialysis therapy.A review of the label for the product family will be conducted.Should additional relevant information become available, a supplemental report will be submitted.
|
|
Search Alerts/Recalls
|
|
|